Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Dunelm appoints Sainsbury's Clodagh Moriarty as new CEO

(Sharecast News) - Homeware retailer Dunelm said on Monday that it has appointed Clodagh Moriarty - currently the chief retail and technology officer at Sainsbury's - as chief executive officer with effect from 1 October. Moriarty will succeed Nick Wilkinson, whose departure was announced in February, following seven years in the role.

Dunelm said Wilkinson will stay on in his role until Moriarty's appointment to ensure a smooth transition, and will step down from the board at the end of September, before leaving the business in early October.

The company said Moriarty is "an established retail leader". As a member of the operating board at Sainsbury's, she holds responsibility for all stores and their operations, alongside the supermarket chain's digital offer and strategy, customer experience and end to end technology platforms.

Moriarty has been with Sainsbury's for 15 years, holding a variety of leadership roles, having previously worked for nine years at Bain & Company.

Chair Alison Brittain said: "We are thrilled to be appointing Clo as our new CEO. She is a proven industry leader and brings an impressive range of skills and experience from one of the UK's largest retailers, where she has played a prominent role in developing the Sainsbury's offer to drive market share gains over a number of years.

"Clo was the standout candidate from a strong field, and we are delighted that we have been able to attract such a talented and high calibre executive. As Nick hands on the baton, we are confident that her blend of retail, digital and strategic expertise will be a significant asset as we move into our next phase of growth as The Home of Homes."

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.